18:33:46 EDT Wed 08 Jul 2026
Enter Symbol
or Name
USA
CA



Precision Peptide Company Inc (The)
Symbol BPC
Shares Issued 47,231,207
Close 2026-07-08 C$ 0.55
Market Cap C$ 25,977,164
Recent Sedar+ Documents

Precision Peptide talks up MMA.INC partnership

2026-07-08 16:50 ET - News Release

Mr. Pratap Sandhu reports

THE PRECISION PEPTIDE COMPANY PROVIDES MMA.INC PARTNERSHIP UPDATE AHEAD OF CONOR MCGREGOR'S UFC 329 RETURN

The Precision Peptide Company Inc. has provided an update on its previously announced exclusive strategic marketing agreement with Mixed Martial Arts Group Ltd. (MMA.INC) as global attention on combat sports intensifies ahead of Conor McGregor's scheduled return to the UFC (Ultimate Fighting Championship) on July 11, 2026.

Mr. McGregor returns: a global moment for combat sports

Mr. McGregor, former UFC champion and one of the most globally recognized figures in combat sports, is scheduled to headline UFC 329 against Max Holloway on July 11, 2026, at T-Mobile Arena in Las Vegas. The welterweight fight marks Mr. McGregor's first UFC appearance in five years and is widely regarded as one of the most anticipated events on the 2026 combat sports calendar.

Mr. McGregor serves as a strategic adviser to MMA.INC, and his return to the octagon is expected to drive significant global viewership, consumer engagement and commercial activity across the combat sports ecosystem. As MMA.INC's sole and exclusive peptide partner, the company is expected to be commercially positioned within that ecosystem at a time when audience attention on athletic performance, recovery and wellness is at its highest.

The company's position inside the ecosystem

Since entering into the agreement in May, 2026 (see news releases dated May 12, 2026, and May 21, 2026), the company has held the exclusive right to market its peptide products across MMA.INC's entire digital footprint. No other peptide company has access to the platform. The company is the only peptide brand integrated into an ecosystem that sits at the intersection of combat sports participation, athletic recovery and performance optimization -- categories that attract consumers with high engagement, strong brand loyalty and consistent repeat purchasing behaviour.

The physical demands of Brazilian jiu-jitsu, mixed martial arts, wrestling, boxing and related disciplines drive consumer interest in recovery and resilience solutions. The company believes this creates a natural alignment between its product offering and the audience MMA.INC has assembled.

The scale of MMA.INC's platform

MMA.INC has built what the company considers the largest digitally connected combat sports ecosystem in the world. As publicly disclosed by MMA.INC, the platform now spans over five million social media followers, approximately 530,000 user profiles, more than 100,000 active students, over 18,000 published gym profiles and more than 800 verified gym partners across 22 countries. Users access the ecosystem through TrainAlta, BJJLink, Hype and MixedMartialArts.com, all unified under a single sign-on infrastructure.

MMA.INC's leadership and advisory roster

As publicly disclosed by MMA.INC, members include:

  • John Kavanagh, co-founder of MMA.INC and Mr. McGregor's long-time head coach;
  • Mr. McGregor, former UFC champion and strategic adviser to MMA.INC;
  • Donald Trump Jr., strategic adviser to MMA.INC and director of Trump Media and Technology Group;
  • Laura Sanko, board director of MMA.INC and the first female colour commentator in UFC history.

U.S. manufacturing and quality standards

The company manufactures all of its peptide products in the United States and subjects them to third party testing protocols focused on purity, consistency and quality assurance. The company views this infrastructure as a competitive advantage as the broader industry moves away from fragmented offshore supply chains and toward domestically manufactured, quality-controlled alternatives.

How the economics work

The agreement provides for a net revenue share on all sales sourced through MMA.INC's platform. During the first 12 months, net revenue is split equally between the parties on a 50/50 basis. From month 13 onward, the split shifts to 75/25 in favour of the company. A 12-month tail period applies following any termination, during which the company continues to pay MMA.INC's share on referred customers. The company made no upfront capital investment to secure the partnership.

All peptide products sold under the agreement are manufactured in the United States and comply with applicable U.S. regulatory requirements, including those set by the U.S. Food and Drug Administration.

Pratap Sandhu, chief executive officer of The Precision Peptide Company, commented: "Conor McGregor's return to the UFC is a defining global moment for combat sports, and it puts a spotlight on the entire ecosystem we are now commercially connected to through our exclusive partnership with MMA.INC. With McGregor, Donald Trump Jr., John Kavanagh and Laura Sanko behind MMA.INC and the company as the platform's sole peptide partner, we believe we are positioned in front of one of the largest and most engaged performance-driven audiences in the world at this time.

"Combined with our commitment to U.S. manufacturing and third party testing, this partnership positions the company to become the peptide brand of choice for one of the world's most performance-driven consumer audiences."

Nick Langton, founder and chief executive officer of MMA.INC., also commented: "We are pleased to have The Precision Peptide Company as our exclusive peptide partner as MMA.INC continues to scale its global ecosystem. The partnership opens a new commercial vertical for MMA.INC in an area where we see strong alignment with our community: recovery, performance, longevity and preventative health."

Further details regarding product launches, marketing campaigns and commercialization milestones are expected to be announced in subsequent updates.

About The Precision Peptide Company Inc.

The Precision Peptide Company is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.